Axol is a specialist CRO building and using better human disease models with human iPSCs for neurodegenerative / neuroinflammatory drug discovery and cardiotoxicitiy.
Case Study
Learn how leading drug discovery companies have benefited from Axol Bioscience's expertise.
View case study.
PRESS RELEASE: NETRI and Axol Bioscience announce their partnership
PRESS RELEASE: NETRI and Axol Bioscience announce their partnership
NETRI and Axol have partnered to provide organs-on-chip kits containing NETRI’s devices and human iPSCs from Axol.
NETRI is a French start-up that develops organs-on-chip technologies for pre-clinical neuroscience discovery and through it’s strategic partnership with Axol, will provide Axol’s iPSC derived cells and optimised protocols to their customers of their DuaLink platforms.